Biopharma firm AbbVie opens S$400m biologics plant in Tuas
The 120,000-sq metre facility, its first manufacturing plant in Asia, will create 250 jobs
Singapore
GLOBAL research and development-based bio-pharmaceutical company AbbVie has enlarged its footprint in Singapore.
On Wednesday, it opened a new biologics manufacturing plant in Tuas, which will expand its manufacturing capabilities for biologics, which are commercial products derived from biotechnology. (Vaccines are one example.)
TRENDING NOW
CSE Global independent director quits after clashes with chairman Eugene Lai over board refresh
‘I felt like dying’: Thai Singha beer scion speaks up after disclosure of alleged sexual abuse
Cat A COE rate exceeds Cat B for third time in 4 months; premiums largely down
What’s wrong with Orchard Road? Experts weigh in on the street’s cachet and its future